Is Insulet Corporation (PODD) undervalued? · P/E 34, rev $2.07B
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
This page asks whether Insulet Corporation (PODD) looks cheap on cached numbers — not a DCF toy and not a buy alert.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
PODD currently screens at market cap $9.94B and trailing P/E 33.5. Cheap versus history or peers still needs a filing reason; a low multiple can be a value trap.
A new PODD 10-Q can flip this screen overnight. The SEC page is the source.
Not investment advice. Compare PODD to the stock page model before you treat a low multiple as a gift.
Not investment advice.